Business · 15/03/2011Updated: 10/17/2026 · 1 min read
FDA Amends IND and NDA Regulations for Accuracy
Summary
The Food and Drug Administration (FDA) is updating its regulations for investigational new drug applications (INDs) and abbreviated new drug applications (NDAs) to correct errors and improve clarity, following a review of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Original source language: Federal Register — Health and Human ServicesOpen original release →